Omega-3 for the Eyes: DHA and Normal Vision

Last updated: March 2026 · Reading time: approx. 10 min.

Your eyes consist to a considerable extent of fat — and one particular fat plays an outstanding role: DHA (docosahexaenoic acid), a long-chain omega-3 fatty acid. The retina is one of the most DHA-rich tissues in the entire human body. It is therefore no surprise that the European Food Safety Authority (EFSA) has recognised an official health claim: DHA contributes to the maintenance of normal vision — provided you take at least 250 mg DHA daily. This article explains how DHA works in the retina, what studies show about omega-3 and age-related macular degeneration (AMD), and which dosages have been investigated.

DHA: The Most Important Building Block of the Retina

The photoreceptors of the human retina — the rods and cones that convert light into electrical signals — show an extraordinarily high DHA concentration. In the outer segments of the rods, DHA can account for up to 50% of all fatty acids. This extreme accumulation is not coincidental: DHA gives cell membranes a particular fluidity and flexibility that is essential for rapid signal transmission in the visual process.

When light strikes a rhodopsin molecule, it must deform within milliseconds to trigger the visual signal. This conformational change works better the more fluid the surrounding membrane is — and that is precisely what DHA provides. Without adequate DHA supply, signal transmission speed in the retina can be impaired.

EFSA Health Claim: DHA and Normal Vision

According to EFSA (EU Regulation No. 432/2012): DHA contributes to the maintenance of normal vision. This health claim is approved for products that provide at least 250 mg DHA per daily dose. The claim may only be used if the total daily intake of EPA+DHA does not exceed 5,000 mg.

The eye's need for DHA is high throughout life. Since the body can only produce DHA from the precursor ALA (alpha-linolenic acid) from plant sources very inefficiently — the conversion rate is less than 1% — direct intake through oily sea fish or supplements is particularly relevant for many people. More on the biochemical background in the article on DHA (Docosahexaenoic Acid).

Age-Related Macular Degeneration (AMD): What Studies Show

Age-related macular degeneration is worldwide one of the most common causes of vision loss in people over 50. In AMD, the light-sensitive cells in the macula lutea — the area of sharpest vision — become progressively damaged. Two main forms are distinguished: dry AMD (geographic atrophy) and neovascular (wet) AMD, in which new blood vessels grow pathologically into the retina.

Whether high omega-3 intake can influence AMD risk has been investigated in several large observational studies and meta-analyses.

AREDS Report 30: 12-Year Observation with 1,837 Participants

Cohort Study American Journal of Clinical Nutrition, 2009

AMD Risk: AREDS Study over 12 Years

In a 12-year observational study of 1,837 people with moderate to high AMD risk — embedded in the large Age-Related Eye Disease Study (AREDS) — the group with the highest omega-3 intake (primarily DHA and EPA from fish) showed a 30% lower risk of geographic atrophy (OR 0.65; P ≤ 0.02) and a 32% lower risk of neovascular AMD (OR 0.68; P ≤ 0.02) compared to the group with the lowest omega-3 intake.

SanGiovanni JP et al. (AREDS Report 30) — PMID 19812176

The AREDS study is particularly significant because it was conducted over a long period of 12 years and encompassed a large sample. Participants were observed with regard to their dietary habits, particularly fish consumption. The results suggest that regular intake of long-chain omega-3 fatty acids — primarily DHA and EPA — is associated with a markedly reduced risk of both main forms of AMD.

Important to note: this is an observational study showing an association, but not proving direct causality. Nevertheless, the effect sizes are remarkably consistent.

2024 Meta-Analysis: Confirmation on a Broad Data Basis

Meta-Analysis Frontiers in Nutrition, 2024

AMD Prevention: Diet-Based Omega-3 Intake

A current 2024 meta-analysis of observational studies examined the association between long-chain omega-3 fatty acids (LCPUFAs) and AMD. The result: a high intake of LCPUFAs (DHA, EPA or DHA+EPA) was significantly associated with a reduced risk of age-related macular degeneration — compared to a low intake. The authors concluded that nutritional status regarding marine omega-3 fatty acids could play a relevant role in AMD prevention.

Frontiers in Nutrition — DOI 10.3389/fnut.2024.1403987

This meta-analysis underscores the findings of the AREDS report and shows that the association between omega-3 and reduced AMD risk is consistent across different study populations. DHA alone, EPA alone and the combination DHA+EPA were all investigated — all three variants showed a significant association.

How DHA Protects the Retina: Biological Mechanisms

Beyond its structural role in photoreceptor membranes, there are several further mechanisms through which DHA and EPA might influence eye health:

Anti-inflammatory Effect

Chronic local inflammatory processes play an essential role in the development and progression of AMD. EPA and DHA are precursors of so-called resolvins, protectins and maresins — inflammation-resolving lipid mediators that actively promote the resolution of inflammatory reactions. In particular, neuroprotectin D1 (derived from DHA) has been detected in the retina and showed protective effects on retinal pigment epithelial cells in laboratory studies.

Oxidative Stress and Drusen Formation

In dry AMD, deposits called drusen accumulate beneath the retina. Oxidative stress accelerates this process. Omega-3 fatty acids can modulate oxidative stress, although as polyunsaturated fatty acids they are themselves susceptible to oxidation — which is why the quality and degree of oxidation of an omega-3 supplement are important. More in the article on correct omega-3 dosage.

Vascular Function in the Retina

The retina is highly dependent on intact blood supply. EPA and DHA demonstrably improve vascular function and tone, reduce platelet aggregation and counteract atherosclerosis. This could be particularly relevant in wet AMD, where pathological new vessel formation (neovascularisation) threatens vision.

Omega-3 and Dry Eyes: The Most Common Eye Complaint

Besides AMD, dry eye (keratoconjunctivitis sicca) is the most common eye-specific topic in omega-3 research. Studies show that EPA and DHA can stabilise the tear film and reduce inflammation of the ocular surface. A detailed article with meta-analysis data from 17 randomised trials can be found here: Omega-3 for Dry Eyes.

Evidence Overview: Omega-3 and Eye Health

Study / Source Design Participants / Duration Most important finding
SanGiovanni et al. 2009
Am J Clin Nutr, PMID 19812176
Cohort study (AREDS) 1,837 persons, 12 years −30% geographic atrophy, −32% neovascular AMD
Frontiers in Nutrition 2024
DOI 10.3389/fnut.2024.1403987
Meta-analysis Multiple observational studies High LCPUFA intake significantly associated with reduced AMD risk
Giannaccare et al. 2019
Cornea, PMID 30702470
Meta-analysis (17 RCTs) 3,363 patients Significant improvement in symptoms, tear film, Schirmer test
EFSA Health Claim
EU Regulation No. 432/2012
Regulatory approval Minimum dose: 250 mg DHA/day DHA contributes to the maintenance of normal vision

Dosage: How Much DHA for the Eyes?

The EFSA health claim for normal vision applies from a daily DHA intake of 250 mg. This amount is comparatively low and corresponds roughly to the DHA content of an average portion of oily sea fish (e.g. salmon or mackerel) per week.

In the above-mentioned AMD studies, omega-3 intake was predominantly diet-based — from fish — rather than from isolated supplements. This does not mean that supplements are less effective; it does show, however, that even moderate, regular intakes from food could be associated with study results.

Practical tip: DHA and vision

For the EFSA-approved health claim for normal vision, 250 mg DHA daily suffices. A high-quality fish oil supplement or algae oil (for vegetarians and vegans) can reliably supply this amount. When buying, look for high DHA concentration, low TOTOX value (freshness/oxidation) and certified purity. More on quality in the buying guide.

For AMD prevention, no specific dosages have been isolated in studies — research has so far been based primarily on dietary patterns. A general recommendation, supported by the German Nutrition Society (DGE), is: at least 1–2 portions of oily sea fish per week or corresponding supplementation. The precise dosage question is addressed in our article Omega-3 Dosage per Day.

DHA in Pregnancy: Eye Development of the Baby

DHA is not only important for adult eyes — it is also essential for the eye development of the unborn child. EFSA has approved a further health claim for this: DHA contributes to the normal development of the eyes of foetuses and breastfed infants when the mother takes at least 200 mg DHA additionally per day (at least 450 mg DHA+EPA total, of which at least 200 mg DHA).

The retina of the foetus develops intensively in the last trimester of pregnancy and then needs particularly large amounts of DHA. Adequate maternal DHA supply is therefore especially important during pregnancy.

Quality of the Omega-3 Supplement: Why It Particularly Matters for the Eyes

The photoreceptors of the retina are especially vulnerable to oxidative stress due to their high DHA concentration and constant light exposure. Fresh, non-oxidised omega-3 is therefore not only a general quality consideration but has particular relevance for eye health applications.

What to Look for When Buying

A good omega-3 supplement for eye health should meet the following criteria:

Oxidised omega-3: counterproductive

Rancid (oxidised) fish oil can itself generate oxidative stress. Studies show that omega-3 products with high TOTOX values may potentially negate the possible benefits. Buy omega-3 in dark bottles, store it cool and away from light, and use it promptly after opening.

Omega-3 from Food vs. Supplements: What Do Studies Say?

Most major AMD studies, including AREDS, measured omega-3 intake from diet — primarily from fish. A direct randomised intervention study specifically using omega-3 supplements for AMD prevention is still outstanding. The AREDS2 study, for example, examined lutein/zeaxanthin and omega-3 supplements and found no significant additional benefit from supplements versus the standard formula — which may however have methodological reasons (including high baseline omega-3 levels among study participants).

This does not mean that supplements are ineffective — particularly for people with low fish consumption, they can be a sensible addition. However, the evidence emphasises that regular fish consumption as part of a Mediterranean dietary pattern is a well-documented strategy for eye health.

Frequently Asked Questions

How much DHA do I need daily for vision?

The EFSA-approved health claim "DHA contributes to the maintenance of normal vision" applies from a daily intake of 250 mg DHA. This amount is provided, for example, by one portion of oily sea fish (salmon, mackerel, herring) per week or a corresponding fish oil or algae oil supplement. For AMD prevention there is no specific evidence-based dosage recommendation from supplement studies — here the research is based on dietary patterns.

Can omega-3 prevent or cure AMD?

Studies — including AREDS Report 30 and a 2024 meta-analysis in Frontiers in Nutrition — show an association between high omega-3 intake and reduced AMD risk. The reduction in AREDS was 30–32% for two forms of AMD. Omega-3 is not considered a cure for AMD, however. With existing AMD, ophthalmological treatment is required. The study data relate to prevention or risk reduction, not therapy.

Is algae oil as effective as fish oil for the eyes?

Fish contain DHA because they eat marine algae that produce DHA. High-quality algae oil contains DHA in comparable form and amount to fish oil. For vegetarians, vegans or people with fish allergies, algae oil is therefore an equivalent alternative for DHA supply — including for the EFSA health claim for normal vision.

What is the difference between dry and wet AMD?

In dry AMD (geographic atrophy), visual cells slowly die off — drusen deposits form beneath the retina. Approximately 85–90% of all AMD cases are dry. Wet (neovascular) AMD is less common but more severe: here, new blood vessels grow pathologically into the retina and can rapidly cause visual deterioration. Studies show associations of omega-3 with both forms, with AREDS reporting similar risk reductions for both.

Can I take omega-3 if I already have AMD?

Omega-3 is generally safe as a dietary supplement for adults at normal doses (up to 5 g EPA+DHA daily, according to EFSA). With existing AMD, always discuss supplements with your doctor or ophthalmologist, especially if you take anticoagulants (possible interactions). Omega-3 does not replace ophthalmological treatment.

Medical disclaimer

This article is for general information purposes only and does not replace medical advice. All health claims are based on EFSA-approved health claims and published studies. Dietary supplements are not a substitute for a balanced diet and a healthy lifestyle. For vision problems or suspected AMD, consult an ophthalmologist.